Tribute to Chinese Physician's Day

The 2022 World Lung Cancer Conference was held in the form of offline+online in Vienna, Austria from August 6th to 9th. Dr. Qian Fangfei (Communication Author: Professor Han Baohui) in Shanghai Cheung Hospital shows the research results of lung cancer screening in my country in the form of oral reports. , Make full use of the connection between grassroots and three hospitals. While the coverage of early screening is more complete, it saves the social economy cost of screening, thereby greatly improving the overall level of early treatment of lung cancer in my country.

This is Professor Han Baohui, deputy dean of Shanghai Chest Hospital and Director of Respiratory Medicine in 2013. Leading the team and the leading team of Shanghai Xuhui District Health Commission took the lead in carrying out the "early screening of community lung cancer" projects in China, continuing the research results to this day. While practically dedication to the healthy life of the people, it provides accurate information for medical clinical and scientific research.

More than that, Professor Han Baohui took the lead in carrying out lung cancer biological immunotherapy based on dendritic cells in the country; led the development of lung intervention including EBUS technology, fluorescent bronchoscopy technology, and magnetic navigable bronchial mirror technology For new technologies for diagnosis and treatment, lead the organization to compile the completion of the 2018, 2020, and 2022 editions of "Guidelines for the Clinical Diagnosis and Treatment of Lung Cancer of the Chinese Medical Association" ... In 40 years of medicine, Professor Han Baohui continued to pursue excellence in the field of breathing and care for the health of the people.

Continuous innovation: committed to the people breathe smoothly

The common people often say that people are alive. This sounds very shallow, but the importance of "breathing" is very straightforward for everyone. Professor Han Baohui devoted himself to allowing ordinary people to breathe smoothly.

Professor Han Baohui has been devoted to the clinical and transformation of lung cancer for decades. It is one of the earliest experts in China to conduct research on lung cancer targeted therapy, lung cancer molecular epidemiological research and immune combined therapy. Basic lung cancer biological immunotherapy. In 2015, under the leadership of the Shanghai Municipal Government, it signed an agreement with the Czech Republic to cooperate with the "DCVAC/LUCA combined with Kaibi+Pemetus chemotherapy to compare the II stage of non -small cell lung cancer stage II stage II stage II."

In 2012, Professor Han Baohui, as one of the four major global researchers in the world's largest lung cancer molecular epidemiological research, is fully responsible for research in Asia, research results lead the improvement of lung cancer diagnosis and treatment, so that patients can directly benefit from it, laying for precise treatment for precise treatment. Base. In order to improve the diagnostic technology of lung tumor, he took the lead in carrying out a number of new technologies such as the diagnosis and treatment of EBUS technology, fluorescent bronchoscopy technology, and magnetic navigable bronchial lens technology. The project of early lung cancer precision diagnosis and treatment technology integration solutions "project was supported by the key special funding of the Ministry of Science and Technology.

Professor Han Baohui, as the director of the hospital's first hospital's drug clinical trial for more than 12 years, led the team to obtain the qualifications of the National Pharmaceutical Clinical Test Management Institution (GCP) in 2008, and led the Department of Respiratory Medicine to carry out and complete more than 100 clinical research on new lung cancer drugs. Including 29 international studies and more than ten clinical studies in Phase I. At the same time, conduct a number of international multi -center research as a PI. In 2012, as one of the four major global researchers in the global lung cancer molecular epidemiological research (IGNITE), it was responsible for research in Asia.

While serving as the deputy dean of the hospital, Professor Han Baohui paid attention to building a solid foundation for the hospital: with the strong support of the hospital's party and government leadership, the hospital central laboratory was established, forming six major platforms: pathological and immune combination platforms; cell biology platforms; research on research; research Use molecular pathological molecular detection platforms; tumor immunity and immune biological therapy platforms; drug screening and animal model platforms; protein groups and episodes of genetics.

Professor Han Baohui is committed to the standardization of lung cancer and the construction of academic platforms. He led the organization to compile the completion of the 2018, 2020, and 2022 version of "Guidelines for Clinical Diagnosis and Treatment of Lung Cancer of the Chinese Medical Association" to guide clinical standards diagnosis and treatment, improve the prognosis of patients, and help physicians at all levels to conduct medical decision -making Provide professional and leading reference standards. The guide was selected into the Chinese Academy of Medical Sciences "China’ s Important Medical Achievements "in 2020. Written the "Advanced Consensus of Chinese Experts (2019 Edition)", which leads the "advanced non -small cell lung cancer anti -vascular generic drug treatment of anti -vascular generating drugs for the treatment of Chinese experts (2019 edition). Professor Han Baohui also participated in the formulation of the Guide to China Cancer Cancer Treatment (CNCCN), and participated in the formulation of the clinical path of lung cancer in the "Specifications for the diagnosis and treatment of primary lung cancer".

Medical benevolence: turn advanced lung cancer into chronic diseases

Professor Han Baohui has achieved innovative achievements to help China's lung cancer treatment level comprehensively improved. He is also committed to carrying out the prevention of diseases and benefiting more patients with advanced tumor.

"As a medical worker engaged in the clinical diagnosis and treatment of tumors, we shoulders the heavy responsibility of fighting tumors. Our key work is two major aspects. Precision diagnosis and treatment of advanced lung cancer greatly improves the long -term survival rate of advanced lung cancer and turns advanced lung cancer into chronic diseases. "Professor Han Baohui has been emphasizing with the department during his aspect of the Department of Respiratory Medicine.

Professor Han Baohui said that lung cancer is the first malignant tumor in the world's mortality ranking, and the prevention and treatment of lung cancer is urgent. In 2013, he led the team to promote "low -dose spiral CT" to screen lung cancer in Xuhui District, Shanghai, and launched a community -based early lung cancer screening project. This is my country's first project based on the low -dose CT screening of high -risk population in community cancer. The detection rate of early lung cancer was as high as 94%through screening (I, II), which increased by 74.1%compared with the early diagnosis rate of the natural onset group. During the period, lung cancer death decreased by 20%; the project was internationally recognized. In 2019, the hospital and Xuhui District Health Commission launched the "Early Screening and Prevention Integrated Integrated Cancer" project. The project covers 13 community health service centers in Xuhui District. It uses an interconnected information sharing platform to establish a two-way referral mechanism for the specialist hospital-community health service center to form a regional hierarchical diagnosis and treatment system for the prevention and treatment of lung cancer. Preliminary screening-CT screening-diagnosis and treatment-follow-up "full-loop health management services.

Due to the characteristics of science, practicality, and the people, the people have been promoted by the Health Commission of Shandong, Yunnan, Jiangxi, Henan, and Hongkou District, such as Shandong, Yunnan, Jiangxi, Henan, and Shanghai in China. This project has won the third "Top Ten Innovative Measures for Medical Reform of China" nomination award, the tenth phase of Shanghai Medical Workers' Science and Technology Innovation "Starlight Plan" shortlisted award, and the "Early Screening and Prevention of Community Cancer and Integrated" project was rated in 2021 " The Top Ten Cases of Health Shanghai Action "was included in the three-year action plan for the construction of the public health system in the Xuhui District (2020-2022), which was praised by the people.

Holding each other: effortless to educate talents

The year of the year is not like the valley of the tree; the ten -year plan is like a tree; the lifelong plan is like a tree. —— "Tuzi · Quan Xiu"

Guarding the health of the people is inseparable from the cultivation of talents. Professor Han Baohui has cultivated 58 post -doctoral degree, doctoral, and doctors for more than 20 years. He has guided countless practitioners from all over the country to train a large number of outstanding medical talents for the country.

A total of 23 post-doctoral and post-doctoral after-doctoral and postdoctorals were by Professor Han Baohui. , France, Germany, Switzerland and other more than a dozen countries, showing the results of the research results of hospital respiratory lung cancer.

Most of the students of Professor Han Baohui have become the backbone of the industry, and digital has also become an outstanding manager of many three hospitals in the country. He has inherited Professor Han Baohui's strict attitude and pursuit of excellent struggle.

For 40 years of medical treatment, Professor Han Baohui was at the heart of the people's health and continued to pursue excellence in the field of breathing. Communist Party members. Lead the hospital's respiratory disease to the first place in the 2019 Shanghai Three -A Hospital Scientific Research Competitive Evaluation Discipline. The top 100 academic influence of respiratory and critical medicine experts ranked 4th.

8 special lines in the north, Guangzhou -Hangzhou 4 places have been launched! The train will be equipped with 22 academicians including Academician Zhong Nanshan/Master of Chinese Medicine/National Medical Medicine, 145 Hospital Management Experts, and 1,582 medical elites of 1,220 public welfare tour posters. Passengers "intimate contact"! At the same time, the general poster video will cover 13,000 TVs on the subway and platforms on the 1st, 5th, 5th, 8th, 13th and Batong lines in Beijing, and the platform will be played many times a day. It is expected that the number of viewing will exceed 100 million!

Review of wonderful articles:

Tribute to Chinese Physician's Day

Tribute to Chinese Physician's Day

Tribute to Chinese Physician's Day · Healthy China, you and me, we will travel with each other | Centennial inheritance, the original intention will not be changed! Lu Yanli: Using the spirit of Daoji to solve the pain of the people

Tribute to Chinese Physician's Day · Health China, you and me.

Tribute to Chinese Physician's Day

Capture: Zhang Yuhui

Edit: Xiangxue

- END -